SNAI2 and breast carcinoma: Additionally, human studies have confirmed a poor prognosis with elevated SLUG expression not only in breast cancer, but also in esophageal squamous cell carcinoma [15], colorectal carcinoma [17] and lung adenocarcinoma [18].